We are lawyers representing seriously injured individuals due to the incompetence of big companies and reckless practitioners.
12/02/2021
Last week, a federal jury in Cleveland found that three large pharmacy chains — CVS Health, Walmart, and Walgreens — played a substantial role in the opioid epidemic in two Ohio counties, Lake and Trumbull. This ruling marks the first time in the decades-long crisis that the retail section of the drug industry has been held responsible.
If you are in need of legal support or are searching for more information, contact us at (800) 597-1870.
12/01/2021
Monsanto Co. challenged a reward of $86.2 million in damages to a couple who developed cancer after three decades of using Roundup w**d killer. Last week, California’s highest court rejected this objection. It upheld the original ruling of the Roundup case in favor of Alva and Alberta Pilliod.
If you are in need of legal support or are searching for more information, contact us at (800) 597-1870.
11/20/2021
Earlier this week, in Tallahassee, Florida, a federal court jury awarded $13 million to Guillermo Camarillorazo in the latest 3M bellwether trial. Camarillorazo is a U.S. Army sergeant who claimed to suffer hearing damage as a result 3M’s military-issue earplugs. The verdict, under the jurisdiction of Northern District of Florida Chief Judge Mark Walker, included about $800,000 in compensatory damages and $12.25 million in punitive damages. This bellwether trial is the seventh one in a large multi-district litigation (MDL) concerning the Combat Arms Earplugs version 2 (CAEv2). It was the largest award yet for a single plaintiff.
For more information on the 3M bellwether trails and most recent settlement, visit https://bit.ly/3FyRUqt.
If you are in need of legal support or are searching for more information, contact us at (800) 597-1870.
11/17/2021
Earlier this month, a California judge rejected an argument being used in thousands of cases against the pharmaceutical industry for its role in the opioid epidemic. The abuse of these drugs has led to the deaths of over 500,000 people in the United States since the 1990s. Unfortunately, the crisis has worsened during the COVID-19 pandemic. This decision marks the first major legal victory for four opioid manufacturers, which include Johnson & Johnson, Teva, Allergan, and Endo Pharmaceuticals.
Specifically, Judge Wilson declared that, if the companies did engage in misleading marketing, “any adverse downstream consequences flowing from medically appropriate prescriptions cannot constitute an actionable public nuisance.” In other words, it would be impossible to determine the increase in legitimate prescriptions versus those that were ill-acquired. Even so, he acknowledged the seriousness of the opioid epidemic.
If you are in need of legal support or are searching for more information, contact us at (800) 597-1870.
11/13/2021
The U.S. Food and Drug Administration (FDA) recently announced an expanded recall of Chantix (varenicline) to include all lots of 0.5mg and 1mg tablets. Pfizer is pulling the smoking cessation drug because of concerning levels of N-nitroso-varenicline, which may be associated with an increased risk of cancer in humans.
If you are in need of legal support or are searching for more information, contact us at (800) 597-1870.
11/10/2021
In late September, farmworker and environmental groups sued the Environmental Protection Agency (EPA) over its summer re-approval of the w**dkiller paraquat, which is primarily used for soybean, corn, and cotton crop fields. These groups argue that it puts farmworkers at an increased risk for developing Parkinson’s disease, a degenerative brain disease that leads to loss of muscle coordination.
If you or a loved one have been impacted by this litigation, contact us at (800) 597-1870.
A jury recently declared a defense verdict in a lawsuit between 3M and a U.S. Army veteran who claimed she suffered hearing damage after using the company’s Combat Arms Earplugs version 2 (CAEv2). This trial was the fifth one chosen as a test case, or a bellwether, in a multi district litigation (MDL) over the defective earplugs.
For more information on the 3M MDL and most recent settlement, visit https://bit.ly/3q8CJQi.
If you are in need of legal support or are searching for more information, contact us at (800) 597-1870.
11/03/2021
Johnson & Johnson (J&J) and the top three drug distributors previously agreed to a national opioid settlement for 26 billion dollars. However, because that deal is not yet finalized, the pharmacy company is moving forward with a separate deal in Texas.
For the new deal, which is consistent with the nationwide settlement, J&J will pay Texas 297 million dollars to put towards opioid claims from the state and its municipalities. The national deal, then, will no longer included this settlement amount. Additionally, J&J will no longer be a defendant in pending opioid litigation in the state, which includes two bellwether trials planned for early next year.
If you are in need of legal support or are searching for more information, contact us at (800) 597-1870.
10/30/2021
Va**ng ma*****na by teens doubles in last seven years, study says
"Ma*****na va**ng by school-aged youth doubled between 2013 and 2020, a new study found, with reported use within the last 30 days rising seven-fold during the same time period.
The study, published Monday in JAMA Pediatrics, analyzed 17 studies conducted throughout Canada and the United States that involved nearly 200,000 adolescents. The study found that teens in their senior year of high school were most likely to be va**ng ma*****na compared to younger adolescents. In 2018, for example, one in three grade-12 students reported va**ng w**d."
**ng *****na
Ma*****na va**ng by teens rose 7-fold in a mere 7 years, with potentially harmful consequences to adolescent health, a new study found.
10/30/2021
According to the results of a new longitudinal study, using e-ci******es and other to***co products to prevent smoking relapse is not effective. Nearly 13,000 smokers in the United States participated in this research. It is the first study to report on whether cigarette smokers can switch to e-ci******es and successfully quit using ci******es.
If you are in need of legal support or are searching for more information, contact us at (800) 597-1870.
10/27/2021
Lupin Pharmaceuticals issued a voluntarily recall of irbesartan and hydrochlorothiazide tablets. Tests on API batches of these medications revealed possible contamination with a cancer-causing impurity. Both medicines are used to treat high blood pressure and diabetic nephropathy in hypertensive patients with Type 2 diabetes.
If you are in need of legal support or are searching for more information, contact us at (800) 597-1870.
10/25/2021
F.D.A. Authorizes E-Cigarettes to Stay on U.S. Market for the First Time -
"The Food and Drug Administration for the first time on Tuesday authorized an electronic cigarette to be sold in the United States, a significant turn in one of the most contentious public health debates in decades."
******es **e
The agency approved three Vuse va**ng products and said their benefits in helping smokers quit outweighed the risks of hooking youths.
Be the first to know and let us send you an email when DDP Injury Law Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Large, international pharmaceutical companies spend billions of dollars annually to actively promote their products directly to consumers. It goes without saying that the public is constantly bombarded with the "benefits" of certain medications and therapies-which largely promote things such as: improved wellbeing, manhood or just making us feel "better."
For years, these companies were restricted in their ability to market sophisticated and chemically complex medications directly to the public. However, since 1997, they have been allowed to advertise drugs and medical devices directly to consumers. This change in the rule has since created a very competitive marketplace that is often filled with drugs and devices that might not be ready for mass consumption.
At the DDP Injury Law Group, we sympathize with dangerous drug and device victims. We have strong convictions about the responsibility businesses and corporations bear for their drugs, devices, irresponsibility and negligence.
In many cases involving drug and device injuries, the manufacturing companies will often use any technique at their disposal to avoid compensating victims that have been harmed by products that they have created and marketed to the public. With that in mind, our team of experienced professionals know and anticipate the typical drug and device manufacturer legal strategies and will not back down when fighting for the rights of our clients who have been victimized.
Furthermore, we believe that victims should have access to the best legal assistance available. Our firm works only on a contingency basis. That means you are not charged up front fees for our services. We only collect for fees and expenses if we obtain a verdict or settlement for you.
